-
1
-
-
34047103452
-
Mineral metabolism parameters throughout chronic kidney disease stages 1-5 - Achievement of K/DOQI target ranges
-
DOI 10.1093/ndt/gfl718
-
Craver L, Marco MP, Martinez I, Rue M, Borras M, Martin ML, et al. Mineral metabolism parameters throughout chronic kidney disease stages 1-5: achievement of K/DOQI target ranges. Nephrol Dial Transplant. 2007;22:1171-6. (Pubitemid 46523434)
-
(2007)
Nephrology Dialysis Transplantation
, vol.22
, Issue.4
, pp. 1171-1176
-
-
Craver, L.1
Marco, M.P.2
Martinez, I.3
Rue, M.4
Borras, M.5
Martin, M.L.6
Sarro, F.7
Valdivielso, J.M.8
Fernandez, E.9
-
2
-
-
33845700085
-
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
-
DOI 10.1038/sj.ki.5002009, PII 5002009
-
Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31-8. (Pubitemid 44967731)
-
(2007)
Kidney International
, vol.71
, Issue.1
, pp. 31-38
-
-
Levin, A.1
Bakris, G.L.2
Molitch, M.3
Smulders, M.4
Tian, J.5
Williams, L.A.6
Andress, D.L.7
-
3
-
-
40449137964
-
Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD
-
DOI 10.1681/ASN.2007060673
-
Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, et al. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol. 2008;19:615-23. (Pubitemid 351355405)
-
(2008)
Journal of the American Society of Nephrology
, vol.19
, Issue.3
, pp. 615-623
-
-
Isakova, T.1
Gutierrez, O.2
Shah, A.3
Castaldo, L.4
Holmes, J.5
Lee, H.6
Wolf, M.7
-
4
-
-
36849017126
-
The parathyroid is a target organ for FGF23 in rats
-
DOI 10.1172/JCI32409
-
Ben Dov IZ, Galitzer H, Lavi Moshayoff V, Goetz R, Kuro OM, Mohammadi M, et al. The parathyroid is a target organ for FGF23 in rats. J Clin Invest. 2007;117:4003-8. (Pubitemid 350224109)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.12
, pp. 4003-4008
-
-
Ben-Dov, I.Z.1
Galitzer, H.2
Lavi-Moshayoff, V.3
Goetz, R.4
Kuro-o, M.5
Mohammadi, M.6
Sirkis, R.7
Naveh-Many, T.8
Silver, J.9
-
5
-
-
64949152754
-
Hyperparathyroidism in chronic kidney disease: A retrospective cohort study of costs and outcomes
-
Smith DH, Johnson ES, Thorp ML, Yang X, Neil N. Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes. J Bone Miner Metab. 2009;27:287-94.
-
(2009)
J Bone Miner Metab
, vol.27
, pp. 287-294
-
-
Smith, D.H.1
Johnson, E.S.2
Thorp, M.L.3
Yang, X.4
Neil, N.5
-
6
-
-
43749124436
-
Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease
-
DOI 10.1038/ki.2008.64, PII KI200864
-
Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar Zadeh K. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney Int. 2008;73:1296-302. (Pubitemid 351693159)
-
(2008)
Kidney International
, vol.73
, Issue.11
, pp. 1296-1302
-
-
Kovesdy, C.P.1
Ahmadzadeh, S.2
Anderson, J.E.3
Kalantar-Zadeh, K.4
-
7
-
-
33748430950
-
Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom
-
DOI 10.1038/sj.ki.5001726, PII 5001726
-
Hase H, Tsunoda T, Tanaka Y, Takahashi Y, Imamura Y, Ishikawa H, et al. Risk factors for de novo acute cardiac events in patients initiating hemodialysis with no previous cardiac symptom. Kidney Int. 2006;70:1142-8. (Pubitemid 44344086)
-
(2006)
Kidney International
, vol.70
, Issue.6
, pp. 1142-1148
-
-
Hase, H.1
Tsunoda, T.2
Tanaka, Y.3
Takahashi, Y.4
Imamura, Y.5
Ishikawa, H.6
Inishi, Y.7
Joki, N.8
-
8
-
-
83055172414
-
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
-
National Kidney Foundation
-
National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(Suppl 3):S1-202.
-
(2003)
Am J Kidney Dis
, vol.42
, Issue.SUPPL. 3
-
-
-
9
-
-
77949496489
-
KDIGO Clinical practice guideline for the diagnosis, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
-
KDIGO Clinical practice guideline for the diagnosis, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009;76(Suppl 113):S70-S89.
-
(2009)
Kidney Int
, vol.76
, Issue.SUPPL. 113
-
-
-
10
-
-
58149180225
-
Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients
-
Guideline Working Group, Japanese Society for Dialysis Therapy
-
Guideline Working Group, Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial. 2008;12:514-25.
-
(2008)
Ther Apher Dial
, vol.12
, pp. 514-525
-
-
-
11
-
-
44449176014
-
Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: The CHOICE study
-
DOI 10.1093/ndt/gfm849
-
Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, et al. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: the CHOICE study. Nephrol Dial Transplant. 2007;23:1650-8. (Pubitemid 351767752)
-
(2008)
Nephrology Dialysis Transplantation
, vol.23
, Issue.5
, pp. 1650-1658
-
-
Melamed, M.L.1
Eustace, J.A.2
Plantinga, L.C.3
Jaar, B.G.4
Fink, N.E.5
Parekh, R.S.6
Coresh, J.7
Yang, Z.8
Cantor, T.9
Powe, N.R.10
-
12
-
-
70349279879
-
The impact of diabetes mellitus on vitamin D metabolism in predialysis patients
-
Tanaka H, Hamano T, Fujii N, Tomida I, Matsui S, Mikami Y, et al. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone. 2009;45:949-55.
-
(2009)
Bone
, vol.45
, pp. 949-955
-
-
Tanaka, H.1
Hamano, T.2
Fujii, N.3
Tomida, I.4
Matsui, S.5
Mikami, Y.6
-
13
-
-
0035922441
-
Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Renal study investigators
-
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Renal study investigators, et al. Effect of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:851-60.
-
(2001)
N Engl J Med
, vol.345
, pp. 851-860
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
Keane, W.F.4
Mitch, W.E.5
Parving, H.H.6
-
14
-
-
30444452987
-
Efficacy and safety of benazepril for advanced chronic renal insufficiency
-
DOI 10.1056/NEJMoa053107
-
Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med. 2006;354:131-40. (Pubitemid 43076710)
-
(2006)
New England Journal of Medicine
, vol.354
, Issue.2
, pp. 131-140
-
-
Fan, F.H.1
Zhang, X.2
Guo, H.Z.3
Xie, D.4
Ping, Y.C.5
Wei, R.Z.6
Jian, P.J.7
Liang, M.8
Guo, B.W.9
Zheng, R.L.10
Ren, W.G.11
-
15
-
-
34249868434
-
Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats
-
DOI 10.1681/ASN.2006091028
-
Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, et al. Combination therapy with an angiotensinconverting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rat. J Am Soc Nephrol. 2007;18:1796-806. (Pubitemid 46870316)
-
(2007)
Journal of the American Society of Nephrology
, vol.18
, Issue.6
, pp. 1796-1806
-
-
Mizobuchi, M.1
Morrissey, J.2
Finch, J.L.3
Martin, D.R.4
Liapis, H.5
Akizawa, T.6
Slatopolsky, E.7
-
16
-
-
0033055159
-
Calcium modulation of the renin-aldosterone axis
-
Porter L, Conlin PR, Scott J, Brown EM, El-Hajj Fuleihan G. Calcium modulation of the renin-aldosterone axis. J Endocrinol Invest. 1999;22:115-21. (Pubitemid 29137404)
-
(1999)
Journal of Endocrinological Investigation
, vol.22
, Issue.2
, pp. 115-121
-
-
Porter, L.1
Conlin, P.R.2
Scott, J.3
Brown, E.M.4
El-Hajj, F.G.5
-
17
-
-
0026738614
-
Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems
-
Grant FD, Mandel SJ, Brown EM, Williams GH, Seely EW. Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab. 1992;75: 988-92.
-
(1992)
J Clin Endocrinol Metab
, vol.75
, pp. 988-992
-
-
Grant, F.D.1
Mandel, S.J.2
Brown, E.M.3
Williams, G.H.4
Seely, E.W.5
-
18
-
-
0036073755
-
3 is a negative endocrine regulator of the renin-angiotensin system
-
DOI 10.1172/JCI200215219
-
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229-38. (Pubitemid 34787360)
-
(2002)
Journal of Clinical Investigation
, vol.110
, Issue.2
, pp. 229-238
-
-
Li, Y.C.1
Kong, J.2
Wei, M.3
Chen, Z.-F.4
Liu, S.Q.5
Cao, L.-P.6
-
19
-
-
43049104680
-
Oral Calcitriol for the Treatment of Persistent Proteinuria in Immunoglobulin A Nephropathy: An Uncontrolled Trial
-
DOI 10.1053/j.ajkd.2007.12.038, PII S0272638608001558
-
Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial. Am J Kidney Dis. 2008;51:724-31. (Pubitemid 351626254)
-
(2008)
American Journal of Kidney Diseases
, vol.51
, Issue.5
, pp. 724-731
-
-
Szeto, C.-C.1
Chow, K.-M.2
Kwan, B.C.-H.3
Chung, K.-Y.4
Leung, C.-B.5
Li, P.K.-T.6
-
20
-
-
69449097895
-
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: Strong synergism with AT1 receptor antagonist
-
Zhang Y, Deb DK, Kong J, Ning G, Wang Y, Li G, et al. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist. Am J Physiol Renal Physiol. 2009;297:F791-801.
-
(2009)
Am J Physiol Renal Physiol
, vol.297
-
-
Zhang, Y.1
Deb, D.K.2
Kong, J.3
Ning, G.4
Wang, Y.5
Li, G.6
-
21
-
-
34250742377
-
Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study
-
DOI 10.1111/j.1542-4758.2007.00190.x
-
Kimata N, Albert JM, Akiba T, Yamazaki S, Kawaguchi Y, Fukuhara S, et al. Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: the Japan dialysis outcomes and practice patterns study. Hemodial Int. 2007;11:340-8. (Pubitemid 46958589)
-
(2007)
Hemodialysis International
, vol.11
, Issue.3
, pp. 340-348
-
-
Kimata, N.1
Albert, J.M.2
Akiba, T.3
Yamazaki, S.4
Kawaguchi, Y.5
Fukuhara, S.6
Akizawa, T.7
Saito, A.8
Asano, Y.9
Kurokawa, K.10
Pisoni, R.L.11
Port, F.K.12
|